Moreover, RFX7 alterations have been associated with chronic lymphocytic leukemia [5–7], diffuse large B cell lymphoma [4, 8], and acute myeloid leukemia [9] in humans and with lymphoma [4, 10] and leukemia [11] in mouse models. This evidence concerns the gene RFX7 and lymphoma.